Inhibitex to Host Conference Call to Report Third Quarter Financial Results on November 9, 2010
October 29 2010 - 3:18PM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Tuesday, November 9, 2010 at 9:00 a.m. EST to
review the Company’s third quarter financial results and provide an
update on recent corporate developments. The Company will issue a
press release regarding its financial results on the same day,
prior to the conference call.
Webcast Information
To access the conference call, please dial (877) 407-9210
(domestic) or (201) 689-8049 (international). A replay of the call
will be available from 11:00 a.m. Eastern Standard Time on November
9th until December 10, 2010 at midnight. To access the replay,
please dial (877) 660-6853 (domestic) or (201) 612-7415
(international) and reference the account # 286 and the conference
id # 359917. A live audio webcast of the call and the archived
webcast will be available in the News and Events section of the
Inhibitex website at http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to prevent
and treat serious infectious diseases. The Company’s pipeline
includes FV-100, which is in Phase II clinical development for the
treatment of shingles, and INX-189, a nucleotide polymerase
inhibitor in Phase 1 clinical development for the treatment of
chronic hepatitis C infections. The Company also has additional HCV
nucleotide polymerase inhibitors in preclinical development and has
licensed the use of its proprietary MSCRAMM® protein platform to
Pfizer for the development of staphylococcal vaccines.
For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024